Innovaderma Plc (LON:IDP)‘s stock had its “corporate” rating reissued by research analysts at FinnCap in a report issued on Friday, October 6th. They presently have a GBX 400 ($5.31) price objective on the stock. FinnCap’s price objective suggests a potential upside of 49.81% from the stock’s current price.
Innovaderma Plc (IDP) opened at 267.00 on Friday. The stock’s 50 day moving average price is GBX 330.90 and its 200 day moving average price is GBX 314.34. Innovaderma Plc has a 52-week low of GBX 71.00 and a 52-week high of GBX 410.50. The stock’s market capitalization is GBX 33.56 million.
Innovaderma Plc (LON:IDP) last announced its quarterly earnings results on Tuesday, September 12th. The company reported GBX 6 ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of GBX 4.70 ($0.06) by GBX 1.30 ($0.02). The firm had revenue of GBX 886 million for the quarter.
COPYRIGHT VIOLATION NOTICE: This piece of content was first reported by BBNS and is owned by of BBNS. If you are reading this piece of content on another publication, it was stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be viewed at https://baseballnewssource.com/markets/innovaderma-plcs-idp-corporate-rating-reiterated-at-finncap-2/1702911.html.
In related news, insider Ross Andrews bought 15,000 shares of the company’s stock in a transaction on Thursday, July 27th. The stock was bought at an average cost of GBX 343 ($4.56) per share, with a total value of £51,450 ($68,363.01).
Receive News & Ratings for Innovaderma Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovaderma Plc and related companies with our FREE daily email newsletter.